Applied Radiology
LOGIN TO YOUR MYAR CE ACCOUNT
Forgot Your Password? Register Submit
Implementing Digital Breast Tomosynthesis into Clinical Practice

This educational series provides an opportunity to learn about the benefits of DBT in detecting breast cancer and discusses considerations for successfully implementing DBT into breast imaging practices.

These activities have been supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.

Part 1 | The Foundation of Integrating DBT Into Your Practice
Part 1 | The Foundation of Integrating DBT Into Your Practice
Applied Radiology Expert Forum Archived Program
Credits: 1.0 AMA PRA Category 1 credit™  |  1 Category A, ARRT credit  |  1 AHRA CRA credit
CME & CE Effective Date: October 6, 2020  |  CME & CE Expiration Date: October 31, 2022
Format: Self Instructional - Audio Visual, Video with Slides
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.

In this program Dr. Laurie Fajardo shares her experience with the set-up and use of digital breast tomosynthesis (DBT) in clinical practice. Participants will hear about system design, the impact on clinical performance, and how to best manage recall rates. In addition through carefully selected cases, Dr. Fajardo will share her approach to image interpretation and how one can manage DBT workflow effectively.

Laurie L. Fajardo, MD, MBA, FACR, FSBI

Laurie L. Fajardo, MD, MBA, FACR, FSBI
Department of Radiology and Imaging Sciences
University of Utah School of Medicine
Salt Lake City, Utah

To participate select the appropriate profession below.
Part 2 | The Application of Integrating DBT Into Your Practice
Part 2 | The Application of Integrating DBT Into Your Practice
Applied Radiology Expert Forum Archived Program
Credits: 1.0 AMA PRA Category 1 credit™  |  1 Category A, ARRT credit  |  1 AHRA CRA credit
CME & CE Effective Date: October 13, 2020  |  CME & CE Expiration Date: October 31, 2022
Format: Self Instructional - Audio Visual, Video with Slides
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.

In this second program, Dr. Laurie Fajardo discusses the benefits of digital breast tomosynthesis (DBT) for detecting and diagnosing breast cancer and things to consider when planning or implementing DBT into breast imaging practices.

Dr. Fajardo discusses the importance of radiation dose reduction with synthetic 2D, reviews the published literature on the performance of synthetic 2D mammography, and shares how DBT can impact data storage and network data transmission across your PACS and enterprise system.

Laurie L. Fajardo, MD, MBA, FACR, FSBI

Laurie L. Fajardo, MD, MBA, FACR, FSBI
Department of Radiology and Imaging Sciences
University of Utah School of Medicine
Salt Lake City, Utah

To participate select the appropriate profession below.
Part 3 | DBT, Breast Density and Artificial Intelligence
Part 3 | DBT, Breast Density and Artificial Intelligence
Applied Radiology Expert Forum Archived Program
Credits: 1.5 AMA PRA Category 1 credit™  |  1.5 Category A, ARRT credit  |  1 AHRA CRA credit
CME & CE Effective Date: October 20, 2020  |  CME & CE Expiration Date: October 31, 2022
Format: Self Instructional - Audio Visual, Video with Slides
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.

In this final segment of this 3-part series, Dr. Laurie Fajardo addresses the radiologist’s challenges associated with dense breast imaging and interpretation through discussion and case presentation of interval breast cancer. This includes issues associated with assigning breast cancer risk to breast density and qualitative versus quantitative methods for assessing, and reporting breast density and risk assessment.

Further Dr. Fajardo will discuss how to incorporate breast cancer risk assessment into your breast imaging practice and closes the program with a discussion on the current impact of Artificial Intelligence on breast imaging and how it can enhance workflow.

Laurie L. Fajardo, MD, MBA, FACR, FSBI

Laurie L. Fajardo, MD, MBA, FACR, FSBI
Department of Radiology and Imaging Sciences
University of Utah School of Medicine
Salt Lake City, Utah

To participate select the appropriate profession below.
COVID-19 Facts, Findings, and Imaging Manifestations
A Clinical Review: Benefits of Tomosynthesis in Daily Practice
Credits: 1.0 AMA PRA Category 1 credit™  |  1 Category A, ARRT credit  |  1 AHRA CRA credit
CME Effective Date: December 15, 2019  |  CME Expiration Date:December 14, 2021
CE Effective Date: January 17, 2020  |  CE Expiration Date: January 31, 2022
Format: Self Instructional - Audio Visual, Video with Slides
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.

Annual mammography screening can save lives because breast cancer is a progressive disease and early detection enables improved prognosis due to appropriate treatment of small nonpalpable node-negative cancers. Multiple randomized controlled trials and observational studies have shown that mammography can reduce breast cancer mortality by 30% or more.

Digital breast tomosynthesis (DBT) first entered the breast imaging clinical arena when the Food and Drug Administration (FDA) approved DBT in 2011. Multiple studies have shown that DBT is effective in both mammography screening and diagnostic settings. Tomosynthesis has quickly emerged as a practice-changing standard that improves the clinical accuracy of a mammogram by increasing both sensitivity and specificity; thus, reducing the masking effect of overlapping fibroglandular tissue, thereby improving breast cancer detection. The improved accuracy and overall efficiency that DBT provides, will enhance radiologists’ performance and improve the patient experience.

Dean James Phillips, DO

Dean James Phillips, DO
Chairman, Department of Radiology, Samaritan Medical Center
President, Northern Radiology Associates, P.C.
President and Director, Outpatient Imaging
Northern Radiology Imaging, PLLC, Watertown, NY

To participate select the appropriate profession below.
The Role of Digital Breast Tomosynthesis in Breast Cancer Screening, Diagnosis, and Continued Patient Management
The Role of Digital Breast Tomosynthesis in Breast Cancer Screening, Diagnosis, and Continued Patient Management
Credits: 2.0 AMA/PRA Category 1 CME Credit™  | 2.0 Category A, ARRT credit  |  2.0 AHRA CRA credit
CME Effective Date: August 1, 2020  |  Expiration Date: July 31, 2022
CE Effective Date: November 5, 2020  |  Expiration Date: November 30, 2022
Format: Self Instructional - Audio Visual, Video with Slides
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.

Digital breast tomosynthesis, also known as 3D DBT first entered the clinical arena in 2011 when the FDA approved its use. Multiple studies have since shown that tomosynthesis is effective in both the screening and the diagnostic setting. This technology has quickly emerged as a practice-changing standard by increasing both sensitivity and specificity, thereby improving breast cancer detection and the clinical accuracy of mammograms.

This Expert Forum educational program focuses on the impact of digital breast tomosynthesis and the role it plays in all aspects of breast screening. In this program, you will hear from an expert panel consisting of four (4) healthcare professionals from various specialties; who are all involved in the diagnosis, treatment and care of breast cancer patients and who will share their clinical insights and experience.

Amy Thurmond, MD

Amy Thurmond, MD
Radiologist
Women’s Imaging & Ultrasound
Oregon Health & Science University
Portland, Oregon

Lara Williams, MD, FACOG, IFMCP, FAARM

Lara Williams, MD, FACOG, IFMCP, FAARM
OB/GYN
Oregon Clinic for
OB/GYN North
Portland, Oregon

Andy Cramer, MD, FACS

Andy Cramer, MD, FACS
Surgical Oncologist
Clackamas Surgical Associates
Portland, Oregon

Lucy Langer, MD

Lucy Langer, MD
Medical Oncologist
Compass Oncology
Portland, Oregon

To participate select the appropriate profession below.